Our recent studies have shown that myeloid-specific Notch signaling disruption could alleviate renal or lung fibrosis progression by regulating monocyte-derived macrophage recruitment via the CCR2–CCL2 axis (37, 38). Here, CCL2 is linked to pulmonary fibrosis.